Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-05

Clinical Trial Update: Aberrant Gene Expression Prostate Carcinoma

View source ↗

Summary

The document reports a Lahey Clinic-sponsored clinical trial studying aberrant gene expression in prostate cancer, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Lahey Clinic | Conditions: Prostate Cancer | Status: ACTIVE_NOT_RECRUITING